Compassionate use of tezepelumab in near fatal asthma: A case report and review of the literature

TL;DR

A man with near fatal asthma was successfully treated with a single dose of tezepelumab after other treatments failed.

Contribution

This is a rare case of using a biologic agent as rescue therapy for near fatal asthma.

Findings

Tezepelumab was administered on a compassionate basis after high-dose corticosteroids failed.

The patient was successfully extubated 7 days after tezepelumab administration.

The case highlights the potential of biologics in treating severe asthma.

Abstract

A 38-year-old man with near fatal asthma requiring intubation and invasive mechanical ventilation (IMV) was transferred to our hospital. Veno-venous extracorporeal membrane oxygenation (VV-ECMO) was initiated due to hypotension and mediastinal emphysema secondary to barotrauma. Since high-dose systemic corticosteroid therapy failed to relieve the severe bronchospasm, a single dose of tezepelumab was administered on a compassionate basis. This intervention resulted in successful extubation 7 days later. This is a rare case in which a biologic agent was used as a rescue therapy for near fatal asthma. This case is presented along with a review of the relevant literature.

Figures